MedTrace Logo

Risk Burden of Lipoprotein Metabolic Gene Haplotypes

NCT00090441 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4303

Last updated 2013-01-04

No results posted yet for this study

Summary

To investigate the role in coronary heart disease (CHD) of intragenic variation in a network of six genes affecting lipoprotein transport and metabolism.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Intermountain Health Care, Inc.

    lead OTHER

Principal Investigators

  • Jeffrey Anderson, MD · Intermountain Health Care; University of Utah School of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-08-31
Primary Completion
2008-07-31
Completion
2008-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00090441 on ClinicalTrials.gov